The evidence for technical considerations in pancreatic resections for malignancy.
The surgeon who wishes to perform successful resections for malignant processes involving the pancreas has to be conversant with a broad range of topics. There are extensive collections of data that usually give excellent guidance, but sometimes also provide conflicting advice. No matter what the data suggest might work best, the surgeon and local collaborators must be able to deliver the quality care cited in some of these reports; usually it is the best results that are published. There is a difference between results that are statistically significant, clinically significant, and important to the patient, and these concepts should never be confused.
Martin
Ronald F
RF
Department of Surgery, Marshfield Clinic and Saint Joseph's Hospital, 1000 North Oak Avenue, Marshfield, WI 54449, USA. martin.ronald@marshfieldclinic.org <martin.ronald@marshfieldclinic.org>
Zuberi
Kashif A
KA
D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery*; D000714:Anastomosis, Surgical / Q000379:methods; D001786:Blood Glucose / Q000378:metabolism; D004322:Drainage; D005743:Gastrectomy; D005772:Gastrointestinal Transit; D006801:Humans; D007582:Jejunostomy; D008207:Lymphatic Metastasis; D010180:Pancreatectomy / Q000009:adverse effects / Q000379:methods*; D010185:Pancreatic Fistula / Q000453:epidemiology; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000601:surgery*; D016577:Pancreaticoduodenectomy / Q000379:methods / Q000401:mortality; D011183:Postoperative Complications / Q000453:epidemiology; D011184:Postoperative Period; D011788:Quality of Life; D015607:Stents; D016019:Survival Analysis; D015430:Weight Gain
D001786:Blood Glucose